P321-0235 Screening compound: 1'-{1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]piperidine-4-carbonyl}-1,4'-bipiperidine

P321-0235 Screening compound: 1'-{1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]piperidine-4-carbonyl}-1,4'-bipiperidine
P321-0235 Screening compound: 1'-{1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]piperidine-4-carbonyl}-1,4'-bipiperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound P321-0235
1'-{1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]piperidine-4-carbonyl}-1,4'-bipiperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P321-0235

Molecular Formula

C25H35N5O2 (C25 H35 N5 O2)

Compound Name

1'-{1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]piperidine-4-carbonyl}-1,4'-bipiperidine

IUPAC name

1'-{1-[5-(4-methylphenyl)-134-oxadiazol-2-yl]piperidine-4-carbonyl}-14'-bipiperidine

SMILES

Cc(cc1)ccc1-c1nnc(N(CC2)CCC2C(N(CC2)CCC2N2CCCCC2)=O)o1

InChI

InChI=1S/C25H35N5O2/c1-19-5-7-20(8-6-19)23-26-27-25(32-23)30-15-9-21(10-16-30)24(31)29-17-11-22(12-18-29)28-13-3-2-4-14-28/h5-8,21-22H,2-4,9-18H2,1H3

InChI Key

RAHYDITWCJGVJZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27572581

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.369

Distribution Coefficient, logD

-0.187

Water Solubility, LogSw

-3.13

Polar Surface Area

54.020

Acid Dissociation Constant (pKa)

21.95

Base Dissociation Constant (pKb)

10.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

64.00

P321-0235 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P321-0235 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P321-0235?
Check Price and Availability of P321-0235, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P321-0235 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P321-0235
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P321-0235
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P321-0235 available by request